BIOA vs BMRN · rev $9.0M vs P/E 40, rev $1.76B
BioAge Labs, Inc (BIOA) versus Biomarin Pharmaceutical Inc (BMRN) — a side-by-side from cached financials, not a winner call.
BioAge Labs, Inc (BIOA) is a drug manufacturers - specialty & generic company listed on US.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Latest reported BIOA revenue for 2025-12-31 was $9.0M. Net income was -$80.6M. BIOA currently screens at market cap $697.9M.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
BIOA currently screens at market cap $697.9M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Not investment advice. Open the BIOA and BMRN stock pages for the full models.
Not investment advice.